CAPITAL MANAGEMENT CORP /VA
Position in HRMY — Harmony Biosciences Holdings, Inc.
CIK 1074273
GLEN ALLEN, VA
Position in HRMY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$10,395,055
+$1,489,976 QoQ
Shares Held
285,500
-10.2% QoQ
Ownership
0.490%
of shares outstanding
% of Portfolio
1.64%
of 13F equity value
Holder Rank
#36
of 328 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in HRMY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CAPITAL MANAGEMENT CORP /VA holds $19,172,476 across 2 Biotechnology names. HRMY ranks #1 (54.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HRMY |
Harmony Biosciences Holdings, Inc.
This page
|
285,500 | $10,395,055 | |
| 2 | EXEL |
Exelixis, Inc.
|
161,320 | $8,777,421 |
All Filings in HRMY
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,395,055 | 285,500 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $8,905,079 | 317,925 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $10,541,999 | 281,721 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $8,899,454 | 322,912 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $11,141,085 | 352,566 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $11,349,685 | 341,961 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $11,732,433 | 340,960 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $9,506,080 | 237,652 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $7,242,006 | 240,040 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $7,018,018 | 208,994 | Shares | Sole | 2024-05-10 | |
| No filing history on record for this holder in this stock. | ||||||